Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Russo

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Digestive Diseases and Sciences|March 21, 2013
Chronic hepatitis E with neurologic manifestations and rapid progression of liver fibrosis in a liver transplant recipientVinaya C Maddukuri, Mark W Russo, William A Ahrens, et al.
Journal of the American Board of Family Medicine : JABFM|May 21, 2020
Novel Models to Identify Census Tracts for Hepatitis C Screening InterventionsThomas Ludden, Lindsay Shade, Jeremy Thomas, et al.
Hepatology (Baltimore, Md.)|January 27, 2012
Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesisAshley M Lakner, Nury M Steuerwald, Tracy L Walling, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 26, 2014
Survival analysis of patients with stage I and II hepatocellular carcinoma after a liver transplantation or liver resectionRamanathan M Seshadri, Siddesh Besur, David J Niemeyer, et al.
Journal of Gastroenterology and Hepatology|December 23, 2025
Modern Diets, Metabolic Inequity, and Race-Ethnic Disparities: Unraveling the Associations With MASLD and Cancer RiskArunkumar Krishnan, Kunal C Kadakia, Sean Richard Rudnick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapyJørn Herrstedt, Wichit Apornwirat, Ahmed Shaharyar, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2016
Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significanceMark W Russo, Nury Steuerwald, Harry J Norton, et al.
Human Gene Therapy|December 29, 2017
Adeno-Associated Virus Serotype 2 Vector-Mediated Reintroduction of microRNA-19b Attenuates Hepatic FibrosisElizabeth Brandon-Warner, Jennifer H Benbow, Jacob H Swet, et al.
Hepatology (Baltimore, Md.)|December 17, 2016
Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplementsHerbert L Bonkovsky, David E Kleiner, Jiezhun Gu, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 22, 2025
AASLD AST Practice Guideline on Adult Liver Transplantation: Diagnosis and management of Graft-Related complicationsHelen S Te, Vatche G Agopian, Anthony J Demetris, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Digestive Diseases and Sciences|March 21, 2013
Chronic hepatitis E with neurologic manifestations and rapid progression of liver fibrosis in a liver transplant recipientVinaya C Maddukuri, Mark W Russo, William A Ahrens, et al.
Journal of the American Board of Family Medicine : JABFM|May 21, 2020
Novel Models to Identify Census Tracts for Hepatitis C Screening InterventionsThomas Ludden, Lindsay Shade, Jeremy Thomas, et al.
Hepatology (Baltimore, Md.)|January 27, 2012
Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesisAshley M Lakner, Nury M Steuerwald, Tracy L Walling, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 26, 2014
Survival analysis of patients with stage I and II hepatocellular carcinoma after a liver transplantation or liver resectionRamanathan M Seshadri, Siddesh Besur, David J Niemeyer, et al.
Journal of Gastroenterology and Hepatology|December 23, 2025
Modern Diets, Metabolic Inequity, and Race-Ethnic Disparities: Unraveling the Associations With MASLD and Cancer RiskArunkumar Krishnan, Kunal C Kadakia, Sean Richard Rudnick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapyJørn Herrstedt, Wichit Apornwirat, Ahmed Shaharyar, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2016
Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significanceMark W Russo, Nury Steuerwald, Harry J Norton, et al.
Human Gene Therapy|December 29, 2017
Adeno-Associated Virus Serotype 2 Vector-Mediated Reintroduction of microRNA-19b Attenuates Hepatic FibrosisElizabeth Brandon-Warner, Jennifer H Benbow, Jacob H Swet, et al.
Hepatology (Baltimore, Md.)|December 17, 2016
Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplementsHerbert L Bonkovsky, David E Kleiner, Jiezhun Gu, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 22, 2025
AASLD AST Practice Guideline on Adult Liver Transplantation: Diagnosis and management of Graft-Related complicationsHelen S Te, Vatche G Agopian, Anthony J Demetris, et al.
Pageof 13